Lytix Biopharma AS (OSL:LYTIX)
Norway
· Delayed Price · Currency is NOK 9.28
+0.04 (0.43%)
Aug 15, 2025, 4:25 PM CET
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of 633.47 million as of August 15, 2025. Its market cap has increased by 44.12% in one year.
Market Cap
633.47M
Enterprise Value
518.45M
Revenue
608.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
9.28
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has decreased from 720.55M to 633.47M, a decrease of -12.08%. That is a compound annual growth rate of -3.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 633.47M | 57.82% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.11B |
| Nordhealth AS | 2.96B |
| Photocure ASA | 1.63B |
| ArcticZymes Technologies ASA | 1.29B |
| Vistin Pharma ASA | 1.07B |
| Omda AS | 1.02B |
| Gentian Diagnostics ASA | 891.41M |
| Thor Medical ASA | 885.99M |